Olink® Reveal Seamlessly Connects Genomics and Proteomics, Empowering Researchers to Uncover the Dynamic Mechanisms Underlying Biology
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
Olink's (OLK) Acquisition by Thermo Fisher Gets UK CMA Nod
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
Lab Instrument Industry Update - New Commercial Entrants
Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q1 Loss, Lags Revenue Estimates
Olink reports first quarter 2024 financial results
UK's CMA kicks off probe into Thermo Fisher-Olink deal
Sampled Named One of the First Olink® Certified Service Providers
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
Olink reports fourth quarter and full year 2023 financial results
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
Olink announces change of date for Annual General Meeting
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
Olink reports third quarter 2023 financial results
Why Earnings Season Could Be Great for Olink (OLK)
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for
Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength?
Olink Holding stock soars on acquisition by Thermo Fisher Scientific
Why Olink Stock Is Skyrocketing Today
OLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Olink Holding AB (publ) Is Fair to Shareholders
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
Olink to participate in September investor events
Olink Holding AB (publ) (OLK) Q2 2023 Earnings Call Transcript
Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q2 Loss, Misses Revenue Estimates
Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform
Wall Street Analysts Believe Olink Holding AB (publ) Sponsored ADR (OLK) Could Rally 31.22%: Here's is How to Trade
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
Announcing Olink® Explore HT – A New Era in Proteomics
Olink Holding AB (publ) (OLK) Q1 2023 Earnings Call Transcript
Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q1 Loss, Tops Revenue Estimates
Olink Holding AB (publ) Sponsored ADR (OLK) Moves to Strong Buy: Rationale Behind the Upgrade
Olink to report first quarter 2023 financial results on May 11, 2023
3 Medical Info Systems Stocks Countering Industry-wide Headwinds
Olink Holding AB (publ) (OLK) Q4 2022 Earnings Call Transcript
Olink Holding AB (publ) Sponsored ADR (OLK) Beats Q4 Earnings and Revenue Estimates